Comparison of Paclitaxel-Coated Balloon Treatment and Plain Old Balloon Angioplasty for De Novo Coronary Lesions
1
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose: This study compared the angiographic outcomes of paclitaxel-coated balloon (PCB) versus plain old balloon angioplasty(POBA) treatment for de novo coronary artery lesions. At present, there is no available data comparing the efficacy of PCB versus POBA for the treatment of de novo coronary lesions. Materials and Methods: This multicenter retrospective observational study enrolled patients with de novo coronary lesions with a reference vessel diameter between 2.5 mm and 3.0 mm and lesion length ≤24 mm who were successfully treated with PCB or POBA. Angiographic measurements and quantitative coronary analysis were performed before and after the procedure, and at 9 months follow-up. Results: A total of 72 patients (49 receiving PCB and 23 receiving POBA) were enrolled in this study. Late luminal loss was-0.12±0.30 mm in the PCB group and 0.25±0.50 mm in the POBA group (p<0.001). There was a higher percentage of binary restenosis(diameter stenosis ≥50%) in POBA, compared to PCB (30.4%, n=7 vs. 4.1%, n=2, p<0.001). Target vessel revascularization was higher in the POBA group (13.0%, n=3 vs. 0%, p=0.033). Conclusion: PCB treatment of de novo coronary lesions showed better 9-month angiographic outcomes than POBA treatment alone.
Abstract
Purpose: This study compared the angiographic outcomes of paclitaxel-coated balloon (PCB) versus plain old balloon angioplasty(POBA) treatment for de novo coronary artery lesions. At present, there is no available data comparing the efficacy of PCB versus POBA for the treatment of de novo coronary lesions. Materials and Methods: This multicenter retrospective observational study enrolled patients with de novo coronary lesions with a reference vessel diameter between 2.5 mm and 3.0 mm and lesion length ≤24 mm who were successfully treated with PCB or POBA. Angiographic measurements and quantitative coronary analysis were performed before and after the procedure, and at 9 months follow-up. Results: A total of 72 patients (49 receiving PCB and 23 receiving POBA) were enrolled in this study. Late luminal loss was-0.12±0.30 mm in the PCB group and 0.25±0.50 mm in the POBA group (p<0.001). There was a higher percentage of binary restenosis(diameter stenosis ≥50%) in POBA, compared to PCB (30.4%, n=7 vs. 4.1%, n=2, p<0.001). Target vessel revascularization was higher in the POBA group (13.0%, n=3 vs. 0%, p=0.033). Conclusion: PCB treatment of de novo coronary lesions showed better 9-month angiographic outcomes than POBA treatment alone.
참고문헌 (17)
- Brilakis ES, "Perioperative management of patients with coronary stents", J Am Coll Cardiol, 49, pp.2145~2150 (2007)
- Agostoni P, "Is bare-metal stenting superior to balloon an-gioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomized trials", Eur Heart J, 26, pp.881~889 (2005)
- Mintz GS, "Remodeling and restenosis: observations from serial intravascular ultrasound studies", Curr Interv Cardiol Rep, 2, pp.316~325 (2000)
- Vos NS, "Safety and feasibility of a PAclitaxel-eluting balloon angioplasty in Primary Percutaneous coronary intervention in Amsterdam (PAPPA): one-year clinical outcome of a pilot study", EuroIntervention, 10, pp.584~590 (2014)
- Kleber FX, "Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group", Clin Res Cardiol, 102, pp.785~797 (2013)
- Smith SC Jr, "ACC", AHA, American Heart Association Task Force on Practice Guidelines (ACC, pp.AHA, SCAI Writing Committee to Update the 2001 Guidelines for Percutaneous Coronary Intervention)[DOI]
- Smith SC Jr, "ACC", AHA guidelines of percutaneous coronary interventions (revision of the 1993 PTCA guidelines)--executive summary. A report of the American College of Cardiology, J Am Coll Cardiol, pp.2001, 37[DOI]
- Kent KM, "Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute", Am J Cardiol, 49, pp.2011~2020 (1982)
- Haude M, "Quantitative analysis of elastic recoil after balloon angioplasty and after intracoronary implantation of balloon-expandable Palmaz-Schatz stents", J Am Coll Cardiol, 21, pp.26~34 (1993)
- Rensing BJ, "Regional differences in elastic recoil after percutaneous transluminal coronary angioplasty: a quantitative angiographic study", J Am Coll Cardiol, 17(6 Suppl B), pp.34B~38B (1991)
- Liu MW, "Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia", Circulation, 79, pp.1374~1387 (1989)
- Waksman R, "Drug-coated balloons for de novo coronary lesions: results from the Valentines II trial", EuroIntervention, 9, pp.613~619 (2013)
- Kleber FX, "Local paclitaxel induces late lumen enlargement in coro-nary arteries after balloon angioplasty", Clin Res Cardiol, 104, pp.217~225 (2015)
- Pires NM, "Sirolimus and paclitaxel provoke different vascular pathological responses after local delivery in a murine model for restenosis on underlying atherosclerotic arteries", Heart, 93, pp.922~927 (2007)
- Gray WA, "Drug-coated balloons for the prevention of vascular restenosis", Circulation, 121, pp.2672~2680 (2010)
- Axel DI, "Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery", Circulation, 96, pp.636~645 (1997)
- Scheller B, "Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation", J Am Coll Cardiol, 42, pp.1415~1420 (2003)